These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4016437)

  • 1. Schizophrenia with good and poor outcome. III: Neurological 'soft' signs, cognitive impairment and their clinical significance.
    Kolakowska T; Williams AO; Jambor K; Ardern M
    Br J Psychiatry; 1985 Apr; 146():348-57. PubMed ID: 4016437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
    Kolakowska T; Williams AO; Ardern M; Reveley MA; Jambor K; Gelder MG; Mandelbrote BM
    Br J Psychiatry; 1985 Mar; 146():229-39. PubMed ID: 2859067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder.
    O'Reilly K; Donohoe G; Coyle C; O'Sullivan D; Rowe A; Losty M; McDonagh T; McGuinness L; Ennis Y; Watts E; Brennan L; Owens E; Davoren M; Mullaney R; Abidin Z; Kennedy HG
    BMC Psychiatry; 2015 Jul; 15():155. PubMed ID: 26159728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance.
    Williams AO; Reveley MA; Kolakowska T; Ardern M; Mandelbrote BM
    Br J Psychiatry; 1985 Mar; 146():239-46. PubMed ID: 2859068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft signs and neuropsychological performance in schizophrenia.
    Flashman LA; Flaum M; Gupta S; Andreasen NC
    Am J Psychiatry; 1996 Apr; 153(4):526-32. PubMed ID: 8599401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical correlates of neurological soft signs in chronic schizophrenia.
    King DJ; Wilson A; Cooper SJ; Waddington JL
    Br J Psychiatry; 1991 Jun; 158():770-5. PubMed ID: 1678661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenic syndromes, cognitive performance and neurological dysfunction.
    Liddle PF
    Psychol Med; 1987 Feb; 17(1):49-57. PubMed ID: 3575577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive functioning in drug-naive patients with first episode of psychosis before and after treatment.
    Zaytseva Y; Gurovich I; Sarkisyan G; Sarkisyan V
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S155-7. PubMed ID: 21894125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive deficits and neurological signs in schizophrenia.
    Wong AH; Voruganti LN; Heslegrave RJ; Awad AG
    Schizophr Res; 1997 Feb; 23(2):139-46. PubMed ID: 9061810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia.
    Goldstein G; Shemansky WJ; Allen DN
    Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
    Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
    Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
    Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
    Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
    Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive deficits in schizophrenia and other psychotic disorders].
    Fagerlund B; Glenthøj BY
    Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia.
    Buchanan RW; Heinrichs DW
    Psychiatry Res; 1989 Mar; 27(3):335-50. PubMed ID: 2710870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.